Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|27|2883-2891

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.27, 2008-09, pp. : 2883-2891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

By Dirks Nathanael L.   Meibohm Bernd  

Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. : 633-659

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies

By Keizer Ron J.   Huitema Alwin D.R.   Schellens Jan H.M.   Beijnen Jos H.  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 493-507

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and pharmacogenomics of therapeutic monoclonal antibodies

By Yan Li   Davis Hugh M  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 961-964

Future Medicine

Access to resources Recommend Favorite

Characterization of monoclonal antibodies (mAb) against native and recombinant human mannose-binding lectin (MBL)

By Zhao H.   Stahl G.L.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Recombinant Human Polyclonal Antibodies: A New Class of Therapeutic Antibodies Against Viral Infections

By  

Current Pharmaceutical Design, Vol. 12, Iss. 16, 2006-06 ,pp. : 2007-2015

Bentham Science Publishers

Access to resources Recommend Favorite